Literature DB >> 23897559

Silencing of the Smad nuclear interacting protein 1 (SNIP1) by siRNA inhibits proliferation and induces apoptosis in pituitary adenoma cells.

Xianzhen Chen1, Fei Xue, Tianhao Xie, Chun Luo.   

Abstract

Smad nuclear interacting protein 1 (SNIP1) gene encodes a protein that contains a conservative C-terminal forkhead-associated domain and functions as a transcriptional coactivator to regulate cell proliferation and cancer progression. This study aimed to investigate the clinical and biological significance of SNIP1 expression in pituitary adenoma. We analyzed SNIP1 expressions in mouse fibroblast L929 cells and mouse pituitary adenoma AtT-20 cells by Western blotting. SNIP1 gene knockdown by small interfering RNA (siRNA) transfection was performed to evaluate SNIP1 function in pituitary adenoma cell lines. As expected, SNIP1 was found to be upregulated in pituitary adenoma cells. The mRNA and protein levels of SNIP1 were inhibited in AtT-20 cells transfected with siRNAs, which led to decreased proliferation, increased apoptosis, and cycle arrest of pituitary adenoma cells. Concomitantly, c-Myc and cyclin D1 protein levels were reduced. These findings may provide novel targets for the treatment of pituitary adenoma.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23897559     DOI: 10.1007/s13277-013-0873-1

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  12 in total

1.  The molecular basis of FHA domain:phosphopeptide binding specificity and implications for phospho-dependent signaling mechanisms.

Authors:  D Durocher; I A Taylor; D Sarbassova; L F Haire; S L Westcott; S P Jackson; S J Smerdon; M B Yaffe
Journal:  Mol Cell       Date:  2000-11       Impact factor: 17.970

2.  SNIP1: Myc's new helper in transcriptional activation.

Authors:  Lars-Gunnar Larsson
Journal:  Mol Cell       Date:  2006-12-28       Impact factor: 17.970

3.  Hypoxia-inducible factor-1 alpha, in association with TWIST2 and SNIP1, is a critical prognostic factor in patients with tongue squamous cell carcinoma.

Authors:  Xinhua Liang; Min Zheng; Jian Jiang; Guiquan Zhu; Jing Yang; Yaling Tang
Journal:  Oral Oncol       Date:  2010-12-16       Impact factor: 5.337

4.  SNIP1 is a candidate modifier of the transcriptional activity of c-Myc on E box-dependent target genes.

Authors:  Makiko Fujii; Lyudmila A Lyakh; Cameron P Bracken; Junya Fukuoka; Morisada Hayakawa; Tadasuke Tsukiyama; Steven J Soll; Melissa Harris; Sonia Rocha; Kevin C Roche; Shin-Ichi Tominaga; Jin Jen; Neil D Perkins; Robert J Lechleider; Anita B Roberts
Journal:  Mol Cell       Date:  2006-12-08       Impact factor: 17.970

5.  Magmas, a gene newly identified as overexpressed in human and mouse ACTH-secreting pituitary adenomas, protects pituitary cells from apoptotic stimuli.

Authors:  Federico Tagliati; Erica Gentilin; Mattia Buratto; Daniela Molè; Ettore Ciro degli Uberti; Maria Chiara Zatelli
Journal:  Endocrinology       Date:  2010-08-18       Impact factor: 4.736

Review 6.  Regulation of cyclin D1 gene expression.

Authors:  Ini-Isabée Witzel; Li Fang Koh; Neil D Perkins
Journal:  Biochem Soc Trans       Date:  2010-02       Impact factor: 5.407

Review 7.  Non-functioning pituitary adenomas.

Authors:  Yona Greenman; Naftali Stern
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2009-10       Impact factor: 4.690

Review 8.  Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.

Authors:  Albert Beckers; Lauri A Aaltonen; Adrian F Daly; Auli Karhu
Journal:  Endocr Rev       Date:  2013-01-31       Impact factor: 19.871

9.  The FHA domain protein SNIP1 is a regulator of the cell cycle and cyclin D1 expression.

Authors:  Kevin C Roche; Nicola Wiechens; Tom Owen-Hughes; Neil D Perkins
Journal:  Oncogene       Date:  2004-10-28       Impact factor: 9.867

10.  Mutation and genomic amplification of the PIK3CA proto-oncogene in pituitary adenomas.

Authors:  C B Murat; P B S Braga; M A H Z Fortes; M D Bronstein; M L C Corrêa-Giannella; R R Giorgi
Journal:  Braz J Med Biol Res       Date:  2012-07-12       Impact factor: 2.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.